- Home
- JANX vs SCL Comparison
JANX vs SCL Comparison
Compare JANX & SCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- SCL
- Stock Information
- Founded
- JANX 2017
- SCL 1932
- Country
- JANX United States
- SCL United States
- Employees
- JANX N/A
- SCL N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- SCL Package Goods/Cosmetics
- Sector
- JANX Health Care
- SCL Consumer Discretionary
- Exchange
- JANX Nasdaq
- SCL Nasdaq
- Market Cap
- JANX 2.2B
- SCL 1.7B
- IPO Year
- JANX 2021
- SCL N/A
- Fundamental
- Price
- JANX $41.26
- SCL $72.24
- Analyst Decision
- JANX Strong Buy
- SCL Strong Buy
- Analyst Count
- JANX 9
- SCL 1
- Target Price
- JANX $64.67
- SCL $89.00
- AVG Volume (30 Days)
- JANX 414.2K
- SCL 135.8K
- Earning Date
- JANX 11-05-2024
- SCL 10-16-2024
- Dividend Yield
- JANX N/A
- SCL 2.08%
- EPS Growth
- JANX N/A
- SCL N/A
- EPS
- JANX N/A
- SCL 1.52
- Revenue
- JANX $15,127,000.00
- SCL $2,202,180,000.00
- Revenue This Year
- JANX $48.35
- SCL N/A
- Revenue Next Year
- JANX N/A
- SCL $9.67
- P/E Ratio
- JANX N/A
- SCL $47.54
- Revenue Growth
- JANX 94.86
- SCL N/A
- 52 Week Low
- JANX $5.65
- SCL $63.60
- 52 Week High
- JANX $65.60
- SCL $96.68
- Technical
- Relative Strength Index (RSI)
- JANX 44.57
- SCL 34.34
- Support Level
- JANX $43.57
- SCL $76.03
- Resistance Level
- JANX $47.59
- SCL $79.43
- Average True Range (ATR)
- JANX 2.49
- SCL 1.57
- MACD
- JANX -0.15
- SCL 0.03
- Stochastic Oscillator
- JANX 4.38
- SCL 3.88
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.
About SCL Stepan Company
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. Surfactants are chemical agents that affect the interaction between two surfaces. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. Majority of Stepan's revenue comes from the United States.